U.S. Chemicals Stock News

ARMOUR Residential REIT (ARR) opened its latest earnings season update with investors focused on how its recent results line up with a year of shifting quarterly EPS and revenue, including Q4 2025 revenue of about US$225.7 million and EPS of US$1.86. Over the past six reported quarters, revenue has ranged from a loss of US$61.3 million in Q2 2025 to US$225.7 million in Q4 2025, while EPS has swung between a loss of US$0.94 and a gain of US$1.86. This sets up this quarter’s release as a check...

Gentex Corporation recently reported first-quarter 2026 results, with sales rising to US$675.44 million from US$576.77 million and net income increasing to US$98.46 million from US$94.87 million a year earlier, while basic and diluted earnings per share from continuing operations moved to US$0.46 from US$0.42. The combination of stronger revenue and higher earnings per share points to improved operating performance versus the prior year’s quarter, providing fresh context for how Gentex’s...

If you are wondering whether Trade Desk's current share price reflects its true worth, this article walks through the key numbers that matter for you as a long term investor. The stock last closed at US$22.62, with returns of 1.3% over 30 days, but declines of 40.0% year to date and 57.5% over the past year that may have changed how the market views its risk and potential. Recent coverage has focused on how Trade Desk fits within the broader media and advertising technology space and how...

Wondering whether Block is attractively priced at its current level, or if the recent run has already baked in the opportunity. The share price last closed at US$69.93, with returns of 1.8% over 7 days, 16.8% over 30 days, 7.3% year to date, 21.6% over 1 year and a 71.8% decline over 5 years. This gives a mixed picture of how the market has treated the stock. Recent news coverage has focused on Block's position as a major listed name in the diversified financials space and its role in...

PulteGroup (PHM) has just opened the books on Q1 2026 with investors looking back at recent quarters where quarterly revenue moved from US$4.9b in Q4 2024 to US$4.6b in Q4 2025 and basic EPS shifted from US$4.47 to US$2.58 as net income moved from US$913.2 million to US$501.6 million. Over the same stretch, trailing twelve month revenue moved in a tight band around US$17.3b to US$18.0b while trailing EPS eased from US$14.82 to US$11.21, which sets up this new quarter against a backdrop of...

Earlier this week, Hill York Service Company, an EMCOR Group subsidiary, announced it had delivered the state-of-the-art HVAC and mechanical systems package for Inter Miami CF’s new 26,700-seat Nu Stadium in Miami, becoming its official HVAC provider. This high-profile stadium project underscores EMCOR’s capacity to handle complex, multi-trade, large-scale installations that can reinforce its position in mission-critical and specialty mechanical work. Next, we’ll examine how this flagship...

Acadia Healthcare Company (NasdaqGS:ACHC) has appointed David Duckworth as Interim CFO, replacing outgoing CFO Todd Young. Duckworth returns to the role after nearly a decade of prior service as Acadia's CFO. The transition occurs while the company continues its search for a permanent CEO. Acadia Healthcare shares recently closed at $27.34, with the stock up 20.5% over the past 30 days and 1.7% over the past week. Over a longer horizon, returns have been mixed, with a 91.3% return year to...

Recent performance context for Novo Nordisk Novo Nordisk (NYSE:NVO) has been trading around $38.52, with a 1 day return of about 1.6% and a past week move near 5.9%, as investors weigh its broader performance trends. See our latest analysis for Novo Nordisk. While the recent 7 day share price return of about 5.9% contrasts with a 90 day share price return of roughly 38% and a 1 year total shareholder return of around 36%, the pattern points to fading momentum after a stronger stretch earlier...

In mid-April 2026, Magnite announced expanded collaborations with Hearst News and AMC Global Media to power high-impact web, CTV, and live-streaming ad formats using its SpringServe, ClearLine, and Live Scheduler platforms. These partnerships highlight how Magnite is embedding its technology deeper into premium news and entertainment ecosystems, giving advertisers streamlined access to large, highly engaged audiences across linear TV, streaming, and digital video. Next, we’ll examine how...

Kohl's recently disclosed that it will receive a US$550 million refund for tariffs it had previously paid, providing a one-time boost to its reported revenue and earnings. This unexpected tariff refund arrives against a backdrop of earlier guidance for weaker earnings and softer sales, materially improving Kohl's near-term financial flexibility. Next, we’ll examine how this sizable tariff refund reshapes Kohl’s investment narrative, including its margin outlook and balance sheet...

What recent performance says about American Water Works Company American Water Works Company (AWK) has drawn investor attention after a recent share price move, with the stock up about 3% over the past week and roughly 1% over the past month. That follows a year where the total return sits near a 5% decline, even as year-to-date performance is about 3.6% and the past 3 months show roughly a 4.1% gain, prompting closer scrutiny of fundamentals. See our latest analysis for American Water Works...

Wondering whether Webull's share price reflects its true worth, or if the market is mispricing it? This article walks through the key valuation angles you need to see for yourself. Webull's stock last closed at US$6.91, with returns of 6.6% over the past week and 34.7% over the past month, while the 1 year return sits at a loss of 64.6%. Recent headlines around Webull have focused on the stock's sharp swings and what that might imply for investor sentiment and risk appetite. These moves put...

TG Therapeutics recently completed enrollment in a Phase 3 trial of a subcutaneous formulation of BRIUMVI for adults with relapsing multiple sclerosis, comparing every 8- and 12-week dosing to the currently approved intravenous regimen on pharmacokinetics, safety, and clinical outcomes. A key focus of the study is whether subcutaneous BRIUMVI can match the drug exposure of the intravenous form while potentially offering a more convenient administration schedule and expanding its clinical...

W. R. Berkley (NYSE:WRB) has appointed R. Christopher DeLauder as president of Berkley Environmental. The move reflects an internal promotion within a key specialty unit focused on environmental insurance. The leadership change signals a new point person for underwriting, risk focus, and execution inside this subsidiary. The appointment at Berkley Environmental comes as W. R. Berkley shares trade around $68.45, with returns of 3.3% over the past week and 5.3% over the past month. Over a...

Synchrony Financial (NYSE:SYF) has rolled out a co-branded credit card and digital loyalty suite with Chico's, White House Black Market, and Soma. The launch introduces a unified rewards ecosystem across the Chico's FAS brands, focused on women's apparel and lifestyle shoppers. The new products use Synchrony’s PRISM credit decisioning technology to support both in store and digital customer experiences. For investors watching NYSE:SYF, this move comes as the shares trade at $76.62, with a 1...

Why Agnico Eagle Mines is on investors’ radar today Agnico Eagle Mines (NYSE:AEM) is back in focus after recent share price swings, with a 1 day return of 2.5% decline contrasted with a month gain of 8.4% and a past 3 months decline of 7.3%. For investors watching gold producers, that mixed return profile sits alongside reported annual revenue of US$11.91b and net income of US$4.46b, providing a sense of the company’s current scale and profitability. See our latest analysis for Agnico Eagle...

Nurix Therapeutics (NRIX) put its oncology pipeline in focus at the AACR 2026 Annual Meeting, releasing new preclinical data on its pan mutant BRAF, CBL B, and Aurora Kinase A degrader programs. See our latest analysis for Nurix Therapeutics. Nurix’s latest AACR data drop comes after a mixed share price run, with a 14.75% 1 month share price return but a 1 year to date share price decline of 8.25%, while the 1 year total shareholder return sits at 43.84%, hinting at shifting expectations...

If you are wondering whether Charter Communications at around US$241.78 is pricing in too much pessimism or quiet value, the stock's recent history gives you a lot to chew on. The share price has returned 2.5% over the last 7 days and 11.1% over 30 days, while year to date it is up 15.5% but still shows a 27.9% decline over 1 year and a 63.9% decline over 5 years. Recent coverage has focused on how Charter sits within the broader US media space, with investors weighing cable and broadband...

Context for Trinity Capital after recent share performance Trinity Capital (TRIN) has seen mixed share performance lately, with a 2.7% decline over the past day, a small pullback over the past week, and a gain over the past month. Across longer periods the picture is also uneven, with a 5.6% decline over the past 3 months, a modest positive return year to date, and a stronger total return over the past year and multi year periods. See our latest analysis for Trinity Capital. With the share...

Wondering whether COMPASS Pathways at around US$9.15 still stacks up on value or has run ahead of itself? This article breaks down what the recent moves might mean for you as an investor. The stock has recently shown strong momentum, with returns of 37.4% over 7 days, 75.3% over 30 days, 39.7% year to date and 129.3% over 1 year, while the 3 year return sits at 13.2% and the 5 year return at a loss of 76.5%. These swings have come as COMPASS Pathways continues to sit in the spotlight of...

If you are wondering whether Ardelyx at around US$5.96 is priced attractively or not, the key question is how that tag compares with what the business might reasonably be worth. The stock has been volatile recently, with a 5.1% decline over the last 7 days, an 11.4% gain over 30 days, a 3.1% decline year to date, and an 18.7% return over the past year, which may signal changing views on its potential and risk. Recent headlines around Ardelyx have focused on its place in the biotech space and...

Wondering if NetApp at around US$108.40 is priced for opportunity or caution? This article walks through what the current market price might be implying about its value. The stock has recently posted returns of 4.6% over 7 days, 3.9% over 30 days, 1.8% year to date and 25.3% over 1 year. Longer term returns of 81.8% over 3 years and 58.5% over 5 years are figures that many investors will be weighing against the current price. Recent coverage around NetApp has focused on its position in data...

Yum! Brands recently completed a formal strategic review of Pizza Hut, including options such as a potential sale, while also preparing to report its March 2026-quarter earnings and rolling out an upgraded Hut Rewards program to deepen customer engagement. This combination of portfolio reassessment at Pizza Hut and continued momentum at Taco Bell and KFC highlights how Yum! is actively reshaping its brand mix and digital capabilities to support its long-term plans. We’ll now examine how...

If you are wondering whether Birkenstock Holding shares offer good value at today’s price or if the story is already priced in, this article walks through the key signals you need to know. The stock last closed at US$40.66, with returns of 8.7% over the past week and 11.5% over the past month, while the 1 year return sits at a 19.0% decline and the year to date return at a 2.7% decline. Recent trading has been shaped by ongoing interest in consumer brands and by how investors weigh...